Karen Drexler
CIK 1504699 · View on SEC EDGAR ↗
Insider
First SEC filing: June 5, 2026 · Latest: June 5, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 20 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
20 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 29, 2024 | RMD | S | 425 | $214.92 | $91,341 | 8,446 Direct | -4.79% | Disposed | 7.2% (price as of 2026-08-20) |
| Feb. 2, 2023 | RMD | S | 594 | $226.58 | $134,589 | 7,987 Direct | -6.92% | Disposed | 1.7% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 9, 2024 | VBIO | Employee Stock Option (Right to Buy) | Common Stock (3,000) | $0.41 | Aug. 8, 2034 | 3,000 | Acquired |
| Nov. 16, 2023 | RMD | ResMed Common Stock Options | ResMed Common Stock (2,575) | $148.90 | Nov. 16, 2030 | 2,575 | Acquired |
| June 14, 2023 | VBIO | Employee Stock Option (Right to Buy) | Common Stock (25,000) | $0.09 | June 13, 2033 | 25,000 | Acquired |
| June 14, 2022 | VBIO | Employee Stock Option (Right to Buy) | Common Stock (40,000) | $1.75 | June 13, 2032 | 40,000 | Acquired |
| June 14, 2022 | VBIO | Employee Stock Option (Right to Buy) | Common Stock (40,000) | $1.75 | June 13, 2032 | 40,000 | Acquired |
| Dec. 14, 2021 | VBIO | Employee Stock Option (Right to Buy) | Common Stock (18,000) | $4.59 | Dec. 13, 2031 | 18,000 | Acquired |
| Nov. 18, 2021 | RMD | ResMed Common Stock Options | ResMed Common Stock (1,695) | $263.16 | Nov. 18, 2028 | 1,695 | Acquired |
| Nov. 19, 2020 | RMD | ResMed Common Stock Options | ResMed Common Stock | $211.76 | Nov. 19, 2027 | 2,308 | Acquired |
| Nov. 19, 2020 | RMD | ResMed Common Stock Options | ResMed Common Stock (2,265) | $211.76 | Nov. 19, 2027 | 2,265 | Acquired |
| Nov. 21, 2019 | RMD | ResMed Common Stock Options | ResMed Common Stock (3,889) | $146.34 | Nov. 21, 2026 | 3,889 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.